https://oncohemakey.com/role-of-radiation-in-the-treatment-of-leukemias-lymphoblastic-lymphoma-central-nervous-system-disease-and-chloromas/
Role of Radiation in the Treatment of Leukemias: Lymphoblastic Lymphoma, Central Nervous System...
central nervous systemrole ofthe treatmentradiationleukemias
https://www.picmonic.com/playlists/0c31da953fb346cb1bd9b5162399efc4
Denver Shared Lymphomas/Leukemias - 17 Picmonics
Denver Shared Lymphomas/Leukemias - 17 Picmonics
denversharedlymphomasleukemias
https://www.oaepublish.com/articles/cdr.2021.30/image/fig2
Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications...
Schematic of the activation of chimeric kinases. Normal monomeric, membrane bound, FGFR1, on binding ligand, dimerizes and is phosphoactivated but remains...
mechanismsresistanceinhibitorsdrivenleukemias
https://unifind.unisr.it/resource/item/25580?language=en-US
UniSR - UNIFIND - Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias...
Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and...
alternativebcrablsplicevariants
https://www.netce.com/course/content/childhood-leukemias-and-lymphomas/62344/2868?productid=&scrollTo=chap.6
Course Content - #62344: Childhood Leukemias and Lymphomas - NetCE
Cancer is the leading cause of death among children 14 years of age and younger and leukemia and lymphoma are among the most prevalent cancers in children....
course contentchildhood leukemiaslymphomasnetce
https://pubmed.ncbi.nlm.nih.gov/6029167/?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Five transplantable leukemias in the Fischer rat, and their responsiveness to steroids
Five transplantable leukemias in the Fischer rat, and their responsiveness to steroids
the fischerfiveleukemiasratresponsiveness
https://visualping.io/pages/sndx-5613-in-r-r-leukemias-clinical-trial-alerts-4964043
SNDX-5613 in R/R Leukemias: Clinical Trial: Get alerts for the latest updates - Visualping
See the latest updates to SNDX-5613 in R/R Leukemias: Clinical Trial. Subscribe for free to get alerts when changes are detected to SNDX-5613 in R/R Leukemias:...
for the latestclinical trialget alertsleukemiasupdates
https://www.medsci.org/v23p1782.htm
Unraveling Research Trends and Hotspots of Genetic Variants in Acute Leukemias: A Web of Science...
Unraveling Research Trends and Hotspots of Genetic Variants in Acute Leukemias: A Web of Science and Scopus-Based Bibliometric Study
research trendsgenetic variantsacute leukemiasweb scienceunraveling
https://bloodjournal.ru/index.php/coh/en/article/view/598?articlesBySameAuthorPage=1
Acute myeloid leukemias with t(7;21)(p22;q22) translocation, 5q- deletion, CD56 expression, and...
with tacutemyeloidleukemiastranslocation
https://www.mskcc.org/research-advantage/support/technology/available/myb-cbp-inhibitors-leukemias-and-carcinomas
MYB/CBP Inhibitors for Leukemias and Carcinomas | Memorial Sloan Kettering Cancer Center
SUMMARY OF INVENTION A variety of breast and colon carcinomas, as well as the vast majority of acute lymphoblastic and myeloid leukemias (including genetically...
memorial sloan ketteringcancer centercbpinhibitorsleukemias
https://www.prnewswire.com/news-releases/gyala-therapeutics-initiates-phase-iiia-clinical-trial-of-a-car-t-cell-therapy-in-acute-leukemias-with-limited-treatment-options-302681392.html
Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias...
/PRNewswire/ -- Gyala Therapeutics, a clinical-stage biotechnology company developing innovative cell therapies for hematologic malignancies, today announced...
phase iclinical trialcell therapyacute leukemiastherapeutics
https://repositori.upf.edu/items/33b0c829-d7ce-41ad-a07e-bd3ae9e0cedf
e-Repositori UPF :: Polycomb complexes in MLL-AF9-related leukemias
t(9;11)-Induced leukemia is present both in children and adults, and depending on age, can cause predominantly acute lymphoblastic (ALL) or acute myeloid...
eupfmll
https://journals.librarypublishing.arizona.edu/hemepath/article/id/2864/
MDS or M6: The dilemma in classifying early leukemias | Hematopathology
the dilemmamdsclassifyingearlyleukemias
https://ega-archive.org/studies/EGAS00001001795
RNA-sequencing data from 195 B-cell precursor acute lymphoblastic leukemias and mate pair whole...
Fusion genes are potent driver mutations in cancer. In this study, we delineate the fusion gene landscape in a consecutive series of 195 pediatric B-cell pre...
rna sequencingdatabcellprecursor
https://ve.scielo.org/scielo.php?script=sci_abstract&pid=S1315-01622014000400007&lng=es&nrm=iso&tlng=en
Utility of chromosome banding with alu i enzyme for identifying methylated areas in acute leukemias
acute leukemiasutilitychromosomebandingalu
https://unige.iris.cineca.it/handle/11567/710368
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors.
to thesolid tumorshumannkcells
https://haematologica.org/article/view/11998
Hematopoietic cell transplants for acute leukemias | Haematologica
acute leukemiascelltransplants
https://scholars.uky.edu/en/publications/renal-complications-in-acute-leukemias/
Renal complications in acute leukemias - University of Kentucky
university of kentuckyacute leukemiasrenalcomplications
https://healos.ai/icd10/c94
C94: ICD10 Code for Other leukemias of specified cell type | HealOS
C94 is the ICD10 code used for documenting Other leukemias of specified cell type in clinical and billing records.
cell typecodeleukemiasspecified
https://profiles.wustl.edu/en/publications/erratum-dnmt3a-loss-drives-enhancer-hypomethylation-in-flt3-itd-a/fingerprints/
Erratum: DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias (Cancer Cell...
erratumlossdrivesenhanceritd
https://turkjpath.org/text.php?id=1962
Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional...
Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study
acute leukemiascare hospitalevaluationtertiarycross